Skip to main content
search

icon

By August 3, 2017Headlines

Contract research firm Icon is buying Mapi, which provides data and analysis on the economic and other outcome benefits of drugs.

http://www.fiercebiotech.com/cro/icon-enhances-commercialization-arm-mapi-buy-reports-record-q2?mkt_tok=eyJpIjoiTldaaE5tUTBNREkxTURFMCIsInQiOiIrcHNGbUhXcUZTcjdGMmpwakxRRjdMZUU3QVVcL1RSRmlHcVo3Vm5UWjZyY2F2SDN3TXdXOTBpVmxsRVJNREl0TFFmQ1hhMHh5XC9lRzJEaFBiQ1NoTGw4Z3dJYjFBRmFXU0pCY2YzWlwvUFkxeFVRajdLRCtPRjRRbXcySlRUSzVHQyJ9&mrkid=635530&utm_medium=nl&utm_source=internal

Tags:

Related Posts

Headlines
February 6, 2024

Cano

Cano Health apparently cannot, as it declares bankruptcy due to too much debt.  Building primary…
Kevin Roche 0
Headlines
January 24, 2024

Turquoise

Turquoise health raises a fresh $30 million in capital for its price transparency platform, as…
Kevin Roche 0
Headlines
January 24, 2024

CAR-T safety

I am co-f0under of a company that manages cell and gene therapy for health plans.…
Kevin Roche 0

Leave a comment

Close Menu